{"id":1067906,"date":"2020-11-20T14:20:57","date_gmt":"2020-11-20T19:20:57","guid":{"rendered":"https:\/\/www.immortalitymedicine.tv\/chiasma-to-host-an-expert-panel-on-acromegaly-and-the-mpowered-phase-3-trial-results\/"},"modified":"2024-08-18T11:40:46","modified_gmt":"2024-08-18T15:40:46","slug":"chiasma-to-host-an-expert-panel-on-acromegaly-and-the-mpowered-phase-3-trial-results","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/chiasma-to-host-an-expert-panel-on-acromegaly-and-the-mpowered-phase-3-trial-results.php","title":{"rendered":"Chiasma to Host an Expert Panel on Acromegaly and the MPOWERED\u00ae Phase 3 Trial Results"},"content":{"rendered":"<p><![CDATA[NEEDHAM, Mass., Nov.  20, 2020  (GLOBE NEWSWIRE) -- Chiasma, Inc. (NASDAQ: CHMA), a commercial-stage biopharmaceutical company utilizing its delivery platform technology to develop and commercialize oral therapies to improve the lives of patients with rare diseases on burdensome and painful injections, today announced that it will host an expert panel on acromegaly and the results from its recently completed MPOWERED\u00ae Phase 3 clinical trial on Monday, November 30, 2020 at 11:00 am Eastern Time.]]><\/p>\n<p>Read the original:<br \/>\n<a target=\"_blank\" rel=\"nofollow noopener noreferrer\" href=\"http:\/\/www.globenewswire.com\/news-release\/2020\/11\/20\/2130922\/0\/en\/Chiasma-to-Host-an-Expert-Panel-on-Acromegaly-and-the-MPOWERED-Phase-3-Trial-Results.html?f=22&amp;fvtc=5&amp;fvtv=46634288\" title=\"Chiasma to Host an Expert Panel on Acromegaly and the MPOWERED\u00ae Phase 3 Trial Results\">Chiasma to Host an Expert Panel on Acromegaly and the MPOWERED\u00ae Phase 3 Trial Results<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Read the original: Chiasma to Host an Expert Panel on Acromegaly and the MPOWERED\u00ae Phase 3 Trial Results <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/chiasma-to-host-an-expert-panel-on-acromegaly-and-the-mpowered-phase-3-trial-results.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":64,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[1246886],"tags":[],"class_list":["post-1067906","post","type-post","status-publish","format-standard","hentry","category-global-news-feed"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/1067906"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/64"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=1067906"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/1067906\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=1067906"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=1067906"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=1067906"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}